<DOC>
	<DOCNO>NCT01892319</DOCNO>
	<brief_summary>This study conduct Europe Asia . The purpose study ( Diabetes Pregnancy Registry ) evaluate safety treatment insulin detemir pregnant woman diabetes mellitus .</brief_summary>
	<brief_title>An International Non-interventional Cohort Study Evaluate Safety Treatment With Insulin Detemir Pregnant Women With Diabetes Mellitus . Diabetes Pregnancy Registry</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Informed consent obtain data collection Woman positive pregnancy test Diabetes mellitus type 1 2 , diagnose prior conception Currently treat LevemirÂ® injectable antidiabetic treatment ( ) Unchanged basal insulin injectable antidiabetic treatment product ( treated basal insulin ) 4 week prior follow conception Women pregnant 16 week baseline visit exclude study</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>